Skip to main content
Caplight Logo









Sonavex

Sonavex

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://sonavex.com/

Last Round

Seed Round

Jul 28, 2026

Total Funding Raised

$27.15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Sonavex is a medical device company that develops automated 3D ultrasound solutions designed to provide quantitative blood flow and vascular data at the point of care.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

automated 3D ultrasoundmedical deviceAI-powered ultrasoundpoint of care ultrasoundPOCUSMedTechblood flow measurementmedical AIAV fistula maturationvascular accessbioresorbable implantultrasound markercannulation guidancemedical imagingpost-surgical monitoringFDA 510(k) clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sonavex Comparables

Compare Sonavex with similar companies based on industry and business-model similarity.

Sonavex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PatenSee
81%
GE HealthCare Technologies Inc.
72%
Transonic Systems Inc.
70%

Sonavex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJul 28, 2026
Series A ExtensionOct 24, 2024
VC RoundOct 24, 2024
GrantSep 25, 2024
GrantMay 25, 2022
VC Round
Nov 5, 2019

Key People

Founding team and executive leadership

David Narrow

CEO

Executive Team

Sonavex Investors

Notable investors and investment history

Sonavex investors
InvestorRounds
Grey Sky Venture PartnersSeries A
GenHenn CapitalSeries A Extension
Fusion FundSeries A
JSTAR Capital InvestmentsSeries A Extension
Abell FoundationSeries A
NIH RADxGrant
TEDCOConvertible Debt, Series A, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Raised $3.1M in a Seed Round.

  • Jul 25, 2026

    Monthly visitors increased 37% MoM, reaching 3K.

Sonavex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sonavex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sonavex's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range25
Year Founded2013
Last FundingJul 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?